Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
HealthTech Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
HealthTech Capital

HealthTech Capital

Operating

HealthTech Capital: A US-based venture capital firm investing and mentoring early-stage healthtech startups.

Location
Los Altos Hills, CA, US
Founded
2010
Firm
Compare
Portfolio
Employees
Website

Investments

Wavely Diagnostics
Wavely Diagnostics
Seed

Total Raised

$5.6M

Rounds

7

Seed$1.4MJuly 2023
Pre-Seed$2.2MFebruary 2022
DebtFebruary 2021
Nymbl Science
Nymbl Science

Total Raised

$19.8M

Rounds

10

UndisclosedSeptember 2022
GT Metabolic Solutions
GT Metabolic Solutions

Total Raised

$19.7M

Rounds

2

Series A$15MJuly 2022
Junum
Junum

Total Raised

$100k

Rounds

5

Convertible NoteJuly 2022
Agile Therapeutics
Agile Therapeutics
Public

Total Raised

$240.8M

Rounds

17

Post Ipo Equity$24MJuly 2022
De Oro Devices
De Oro Devices

Total Raised

$4.3M

Rounds

2

Seed$2.8MJune 2022
Seed$1.5MFebruary 2022
PhotoniCare
PhotoniCare

Total Raised

$18.2M

Rounds

15

Convertible NoteMay 2022
S2 Genomics
S2 Genomics

Total Raised

$18.2M

Rounds

8

Convertible NoteApril 2022
Convertible NoteApril 2021
CoLabs
CoLabs

Total Raised

$256k

Rounds

3

Series AApril 2022
OtoSet® by SafKan Health
OtoSet® by SafKan Health

Total Raised

$12.9M

Rounds

5

Convertible Note$2.5MApril 2022
Avive Solutions
Avive Solutions

Total Raised

$33.5M

Rounds

8

Series A$22MMarch 2022
Cionic
Cionic

Total Raised

$35.3M

Rounds

5

SeedJanuary 2022
Aquyre Biosciences
Aquyre Biosciences

Total Raised

$22.6M

Rounds

3

Series AJuly 2021
xCures
xCures
Series B

Total Raised

$84M

Rounds

10

Series A$12.7MJune 2021
Bone Health Technologies
Bone Health Technologies

Total Raised

$6.2M

Rounds

7

SeedMay 2021
Madorra
Madorra

Total Raised

$5.6M

Rounds

10

Convertible NoteMarch 2021
Claria Medical
Claria Medical

Total Raised

$12.4M

Rounds

5

Convertible NoteFebruary 2021
IrisVision
IrisVision
Public

Total Raised

$21.7M

Rounds

5

Convertible NoteDecember 2020
Convertible NoteMay 2020
Journey
Journey

Total Raised

$2.6M

Rounds

7

SeedSeptember 2020
Eysz
Eysz

Total Raised

$3.9M

Rounds

7

Seed$1.9MJuly 2020